Goldman Sachs’s Envoy Medical COCH Stock Holding History

Goldman Sachs’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.3K	Buy	+36,462	New	+$24.9K	﹤0.01%	6349
2023 Q1	–	Sell	-200,271	Closed	-$2.01M	–	5957
2022 Q4	$2.01M	Buy	200,271 +30	+0%	+$298	﹤0.01%	3945
2022 Q3	$1.97M	Sell	200,241 -922,315	-82%	-$9.06M	﹤0.01%	3989
2022 Q2	$11M	Hold	1,122,556	–	–	﹤0.01%	2427
2022 Q1	$11M	Sell	1,122,556 -155,600	-12%	-$1.51M	﹤0.01%	2597
2021 Q4	$12.4M	Hold	1,278,156	–	–	﹤0.01%	2556
2021 Q3	$12.4M	Hold	1,278,156	–	–	﹤0.01%	2500
2021 Q2	$12.4M	Buy	+1,278,156	New	+$12.4M	﹤0.01%	2487

Other funds holding COCH

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCA

DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Goldman Sachs's COCH Position: Q1 2026 in Review

Goldman Sachs opened a new position in Envoy Medical (COCH) in Q1 2026: 36,462 shares worth $24.3K. The stake represents ﹤0.01% of the portfolio and ranks #6349 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in COCH as recently as Q4 2022.

Goldman Sachs first reported a position in COCH in Q2 2021 and has held it in 8 quarters since. The position peaked at $12.4M in Q4 2021. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

Goldman Sachs held 36,462 shares of Envoy Medical worth $24.3K as of Q1 2026.
Envoy Medical was a new Goldman Sachs position in Q1 2026.
Envoy Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6349 holding.
Goldman Sachs first reported a position in Envoy Medical in Q2 2021 and has held it in 8 quarters since.
Goldman Sachs's Envoy Medical position peaked at $12.4M in Q4 2021.
33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.